Yolanda van der Graaf

13.4k citations

244 papers · 9.1k indexed · h-index 52

Cardiology and Cardiovascular Medicine top 0.5%
- Blood Pressure and Hypertension Studies 41
- Cardiovascular Health and Disease Prevention 29
- Cardiovascular Disease and Adiposity 27
Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins 38
Internal Medicine top 2%
Pulmonary and Respiratory Medicine top 1%
- Cerebrovascular and Carotid Artery Diseases 33
Surgery top 1%
- Lipoproteins and Cardiovascular Health 37
- Peripheral Artery Disease Management 29
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 26

Co-authors: Frank L.J. Visseren Willem P.Th.M. Mali Ale Algra Diederick E. Grobbee L. Jaap Kappelle Jan Westerink Petra M. Gorter Yvonne T. van der Schouw
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine
Journals: The Lancet (3 papers)Circulation (6 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Yolanda van der Graaf

244 papers receiving 8.8k citations

Peers

Countries citing papers authored by Yolanda van der Graaf

Since Specialization

Citations

This map shows the geographic impact of Yolanda van der Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda van der Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda van der Graaf more than expected).

Fields of papers citing papers by Yolanda van der Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda van der Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda van der Graaf. The network helps show where Yolanda van der Graaf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yolanda van der Graaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yolanda van der Graaf Line = papers co-authored together Yolanda van der Graaf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial BMJ Open ·N E M Jaspers,Frank L.J. Visseren,Yolanda van der Graaf,Yvo M. Smulders,Olga C. Damman,Corline Brouwers,Guy E.H.M. Rutten,Jannick A N Dorresteijn	2021	7
2	Subjective cognitive decline, brain imaging biomarkers, and cognitive functioning in patients with a history of vascular disease: the SMART-Medea study Neurobiology of Aging ·Kim Blom,Huiberdina L. Koek,Maarten H.T. Zwartbol,Yolanda van der Graaf,Lara Kesseler,Geert Jan Biessels,Mirjam I. Geerlings,Yolanda van der Graaf,Diederick E. Grobbee,Guy E.H.M. Rutten,Frank L.J. Visseren,Gert Jan de Borst,L. Jaap Kappelle,Tim Leiner,Pieter A. Doevendans	2019	17
3	Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives BMJ Open ·N E M Jaspers,Frank L.J. Visseren,Mattijs E. Numans,Yvo M. Smulders,Fere A van Loenen Martinet,Yolanda van der Graaf,Jannick A N Dorresteijn	2018	12
4	Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials Cardiovascular Diabetology ·Marit de Jong,H. Bart van der Worp,Yolanda van der Graaf,Frank L.J. Visseren,Jan Westerink	2017	94
5	Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus Journal of the American Heart Association ·Joep van der Leeuw,Joline W. J. Beulens,Susan van Dieren,Casper G. Schalkwijk,Jan F. C. Glatz,Marten H. Hofker,W. M. Monique Verschuren,Jolanda M.A. Boer,Yolanda van der Graaf,Frank L.J. Visseren,Linda M. Peelen,Yvonne T. van der Schouw	2016	60
6	Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus Circulation Cardiovascular Quality and Outcomes ·Lotte Kaasenbrood,Neil R Poulter,Peter S. Sever,Helen M. Colhoun,Shona Livingstone,S. Matthijs Boekholdt,Sara Pressel,Barry R. Davis,Yolanda van der Graaf,Frank L.J. Visseren	2016	9
7	Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial BMJ Open ·Jacoba P. Greving,H. A. H. Kaasjager,Joris W.P. Vernooij,Marcel M.C. Hovens,Judith Wierdsma,H. M. H. Grandjean,Yolanda van der Graaf,G. Ardine de Wit,Frank L.J. Visseren	2015	16
8	Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality Thorax ·Pushpa M. Jairam,Yolanda van der Graaf,Jan‐Willem J. Lammers,Willem P.Th.M. Mali,Pim A. de Jong	2015	50
9	Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease — Results from EUROPA International Journal of Cardiology ·Joep van der Leeuw,Rohit M. Oemrawsingh,Yolanda van der Graaf,Jasper J. Brugts,Jaap W. Deckers,Michel E. Bertrand,Kim Fox,Roberto Ferrari,Willem J. Remme,Maarten L. Simoons,Eric Boersma,Frank L.J. Visseren	2014	8
10	Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study Cardiovascular Diabetology ·Sandra N. Verhagen,Annemarie M.J. Wassink,Yolanda van der Graaf,Petra M. Gorter,Frank L.J. Visseren,(unknown)	2011	29
11	The Prognostic Value of Vascular Diameter Measurements on Routine Chest Computed Tomography in Patients Not Referred for Cardiovascular Indications Journal of Computer Assisted Tomography ·Martijn J. A. Gondrie,Yolanda van der Graaf,P Jacobs,Stan C.F.M. Buckens,Willem P.Th.M. Mali	2011	9
12	Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease Journal of the American College of Cardiology ·Jakub J. Regieli,J. Wouter Jukema,Pieter A. Doevendans,Aeilko H. Zwinderman,John J.P. Kastelein,Diederick E. Grobbee,Yolanda van der Graaf	2009	60
13	Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease American Heart Journal ·Gideon R. Hajer,Yolanda van der Graaf,Jobien K. Olijhoek,Michael Edlinger,Frank L.J. Visseren	2007	28
14	The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease Journal of Vascular Surgery ·Bertine M.B. Goessens,Yolanda van der Graaf,Jobien K. Olijhoek,Frank L.J. Visseren	2007	28
15	Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines on Cardiovascular Disease Prevention: The SMART study Journal of Vascular Surgery ·Bertine M.B. Goessens,Frank L.J. Visseren,Ale Algra,Jan-Dirk Banga,Yolanda van der Graaf	2006	54
16	Plagiocephalometry: a non-invasive method to quantify asymmetry of the skull; a reliability study European Journal of Pediatrics ·Leo A. van Vlimmeren,Tim Takken,Léon N. A. van Adrichem,Yolanda van der Graaf,Paul J.M. Helders,Raoul Engelbert	2005	65
17	Functional health and well-being of relatively young women with peripheral arterial disease is decreased but stable after diagnosis Journal of Vascular Surgery ·Daisy G.M Bloemenkamp,Willem P.Th.M. Mali,Bea C. Tanis,Maurice A. A. J. van den Bosch,Jeanet M. Kemmeren,Ale Algra,Yolanda van der Graaf	2003	15
18	Decision Analyses for Prophylactic Replacement of the Björk-Shiley Convexo-concave Heart Valve: Medical Decision Making ·Ewout W. Steyerberg,Marjon Kallewaard,Yolanda van der Graaf,Lex A. van Herwerden,J. Dik F. Habbema	2000	19
19	Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease The Lancet ·Eric Tetteroo,Yolanda van der Graaf,Johanna L. Bosch,Andries D. van Engelen,M. G. Myriam Hunink,B.C. Eikelboom,Willem P.Th.M. Mali	1998	213
20	Negative Cervical Smears Before CIN 3/Carcinoma Acta Cytologica ·Heleen Doornewaard,Harm van de Seijp,Julia M.C. Woudt,Yolanda van der Graaf,Jan G. van den Tweel	1997	20

About Yolanda van der Graaf

Yolanda van der Graaf is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Internal Medicine, having authored 244 papers that have together received 9.1k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Lipoproteins and Cardiovascular Health (37 papers), Cerebrovascular and Carotid Artery Diseases (33 papers), Peripheral Artery Disease Management (29 papers), Cardiovascular Health and Disease Prevention (29 papers), Cardiovascular Disease and Adiposity (27 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.7k citations), Endocrinology, Diabetes and Metabolism (1.5k citations) and Internal Medicine (255 citations). Yolanda van der Graaf has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Frank L.J. Visseren, Willem P.Th.M. Mali, Ale Algra, Diederick E. Grobbee, L. Jaap Kappelle, Jan Westerink, Petra M. Gorter, Yvonne T. van der Schouw, Pieter A. Doevendans and Mirjam I. Geerlings. Their work appears in journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact